1d
Superinteressante on MSNOs ensaios clínicos pioneiros no campo dos xenotransplantes começarão nos EUA ainda este ano; entenda.Os testes em questão envolvem o transplante de rins de porcos geneticamente modificados em humanos. O primeiro estudo será ...
A EssilorLuxottica anunciou que seu novo dispositivo, o Nuance Audio, recebeu aprovação da Food and Drug Administration ( FDA ...
The drug may provide potential cost savings compared to opioids, but uncertainties about its long-term safety profile persist. Suzetrigine's approval highlights the ongoing need for effective non ...
Um vídeo flagrou a gritaria dentro da Câmara Municipal da capital mineira nesta quarta-feira, 5. A sessão plenária previa a votação do PL 591/2023, que propõe que entidades usem “o sexo biológico como ...
CAPA publishes more than 1,000 global News Briefs every week, covering all aspects of the aviation and travel industry. It’s the most comprehensive source of market intelligence in the world, with ...
The FDA has published its long-awaited update to guidance to make sure clinical trials more closely reflect the range of patients that might be treated with a new therapy in the real world.
The intravenously-administered cephalosporin drug met its objectives in the ERADICATE study in adults with bacterial bloodstream infections caused by Staphylococcus aureus (SAB), setting up an FDA ...
The ACA's elimination of cost-sharing for preventive care is under scrutiny, potentially affecting PrEP and other services. The Supreme Court's review focuses on the constitutionality of USPSTF ...
Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...
Oxide nanoparticles, particularly iron oxide, ceria and silica nanoparticles, hold significant promise for biomedical applications owing to their unique magnetic, catalytic and porous properties ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results